


The fund aims to provide capital appreciation.
| Name | % Net Assets |
|---|---|
| STANDARD LIFE TM PACIFIC BASIN | 8.0% |
| HSBC | 3.6% |
| BP | 3.2% |
| VODAFONE | 2.5% |
| GlaxoSmithKline | 2.4% |
| RIO TINTO | 1.8% |
| Barclays | 1.5% |
| British American Tobacco | 1.4% |
| AstraZeneca | 1.3% |
| Rio Tinto | 1.1% |
| Key | % Net Assets |
|---|---|
| 8.0% | |
| 3.6% | |
| 3.2% | |
| 2.5% | |
| 82.7% |
| Date | 20-Aug-2025 |
|---|---|
| NAV | 511.20p |
| Currency | GBP |
| Change | 2.80p |
| % | 0.55% |
| YTD change | 58.50p |
| YTD % | 12.92% |
| Fund Inception | 01/05/1986 |
|---|---|
| Fund Manager | Jacqueline Kerr |
| TER | 0.61 (28-Sep-2012) |
| Minimum Investment | |
|---|---|
| Initial | £250000 |
| Additional | £50,000 |
| Savings | n/a |
| Charges | |
|---|---|
| Initial | n/a |
| Annual Mang't | 0.50% |
| Exit | n/a |
| Name | % |
|---|---|
| Standard deviation | 0.02 |
| Sharpe ratio | 0.07 |
You are here: research